IMS buys part of Cegedim; Health policy researcher eschew social media (PRVR–6/30 to 7/3/2014)

This week on Pharma Research VIDEO Report:  1) IMS Health’s acquisition of assets of Cegedim vastly increases IMS’ size and may lead to new insights  2) New pharmaceutical research registry announcements.  3) Johnson & Johnson announces new alliances to explore early-stage therapeutic innovations for pharma, medical devices,diagnostics and consumer health.  4) Perelman School of Medicine reveals health policy researchers limit their social media use to communicate research findings  5) IDC Health Insights releases a new report to help payers effectively reach & engage segments of their member populations, which have changed due to ACA.

We want to hear from you

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,746 other followers

%d bloggers like this: